SCHEMBL14686341

SCHEMBL14686341

CS(=O)(=O)[CH]c1cnccc1C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 6/20 0.46
SLC22A12 Q96S37 3/20 0.43
CYP17A1 P05093 2/20 0.40
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 1/20 0.35
ERN1 O75460 1/20 0.34
NPC1 O15118 1/20 0.34
POLB P06746 1/20 0.34
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
NFKB1 P19838 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30149259 0.77 ERN1 (0.48) NFE2L2SLC22A12ERN1NPC1POLB
SCHEMBL844273 0.77 ERN1 (0.48) NFE2L2SLC22A12ERN1NPC1POLB
SCHEMBL25398893 0.77 NFE2L2 (0.39) NFE2L2SLC22A12CYP17A1ERN1NPC1
SCHEMBL4943413 0.74 SLC22A12 (0.46) NFE2L2SLC22A12CYP17A1MEN1CYP1A2
SCHEMBL16446421 0.74 NFE2L2 (0.40) NFE2L2SLC22A12CYP17A1ERN1NPC1
SCHEMBL3663643 0.73 NFE2L2 (0.36) NFE2L2SLC22A12CYP17A1ERN1NPC1
SCHEMBL29988644 0.72 NFE2L2 (0.40) NFE2L2SLC22A12ERN1NPC1POLB
SCHEMBL28823336 0.71 SLC22A12 (0.38) SLC22A12CYP17A1CYP1A2CYP2D6ERN1
SCHEMBL5700277 0.70 SLC22A12 (0.46) NFE2L2SLC22A12CYP17A1MEN1CYP1A2
SCHEMBL28541116 0.70 SLC22A12 (0.43) NFE2L2SLC22A12CYP17A1PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1865940-B1 ALPHA KETOAMIDE COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS VIROBAY INC (US) 2013-02-13 EP claimed